충남대학교외국학술지지원센터

글로벌메뉴

  • HOME
  • sitemap

주메뉴

CNU Search

전체 ㅣ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z ㅣ 가 나 다 라 마 바 사 아 자 차 카 타 파 하 기타
검색 타입
상세검색
검색어[가나다ABC : 전체]
총 116건 중 116건 출력
1/6 페이지 엑셀파일 출력

검색간략리스트

열거형 테이블형
검색리스트 테이블
No 자료
유형		 서명 저자 발행처 원문제공시작년 수록
매체
1 저널기사 Abnormal Coagulation in the Postoperative Period Contributing to Excessive Bleeding/ 미리보기
McKenna, Rajalaxmi Saunders 2001
2 저널기사 Achieving a Safe and Early Discharge for Patients with Community-Acquired Pneumonia/ 미리보기
Rhew, David C Saunders 2001
3 저널기사 Acute Gastrointestinal Bleeding/ 미리보기
Fallah, Marc A Saunders 2000
4 저널기사 Advances in Breast Cancer Detection and Management/ 미리보기
Newman, L. A Saunders 2003
5 저널기사 Advances in Diagnostic and Therapeutic Endoscopy/ 미리보기
Mallery, Shawn Saunders 2000
6 저널기사 Advances in Inflammatory Bowel Disease/ 미리보기
Stotland, Brian R Saunders 2000
7 저널기사 A Health Services Perspective on Delivery of Psychiatric Services in Primary Care Including Internal Medicine/ 미리보기
Anfinson, Theodore J Saunders 2001
8 저널기사 Alcohol Withdrawal/ 미리보기
Chang, Patrick H Saunders 2001
9 저널기사 Alternatives to Estrogen/ 미리보기
Fitzpatrick, L. A Saunders 2003
10 저널기사 Antibiotic Resistance - Antibiotic resistance is agent specific, and is not related to volume or duration of use nor limited to certain antibiotic classes. Antibiotics should be viewed as having little or no resistance potential or having a high resistance potential. Antibiotics with a low resistance potential should not be restricted but those with a high resistance potential should be restricted. The only effective mechanism to control antibiotic resistance is by limiting hospital formularies to include only antibiotics with little or no resistance potential. Physicians in the ambulatory setting need to be more selective in antibiotic prescribing and preferentially select antibiotics with a low resistance potential./ 미리보기
Cunha, Burke A Saunders 2000
11 저널기사 Antibiotic Synergy and Antagonism - This article discusses some current problems in antibacterial combination therapy, including methods of laboratory testing for synergistic effect of antibiotic combinations, synergy and antagonism of known mechanisms as studied in experimental models, and antibiotic combinations available commercially. The author also examines clinical situations where a therapeutic benefit can be expected by prescribing a combination of antibiotics./ 미리보기
Acar, Jacques F Saunders 2000
12 저널기사 Antienterococcal Antibiotics - The spread of enterococci as a major cause of nosocomial infections and the increasing resistance of these organisms to all currently available antibiotics, including glycopeptides, has rendered therapy of these infections particularly difficult. Mechanisms of resistance to antimicrobial agents are now understood to a significant extent. Therapeutic regimens are often based on the results of experimental studies but most often have not been validated by large clinical trials. The main options for the treatment of infection caused by susceptible and resistant enterococci, using commercially available or new therapeutic agents, are reviewed here./ 미리보기
Lefort, Agnes Saunders 2000
13 저널기사 Antimicrobial Pharmacodynamics - Pharmacodynamics is a science that integrates microbiological and pharmacokinetic data into more clinically relevant relationships. An understanding of pharmacodynamic concepts is essential for the clinician, for it forms the scientific basis for rational antimicrobial chemotherapy. Herein, fundamental pharmacodynamic principles and their application to clinical practice are discussed./ 미리보기
Ambrose, Paul G Saunders 2000
14 저널기사 Attention-Deficit/Hyperactivity Disorder Attention-deficit/hyperactivity disorder (ADHD) is the most frequently diagnosed childhood psychiatric disorder. Many children with ADHD continue to exhibit its symptoms of inattention, hyperactivity, and impulsivity as adults and require treatment throughout their life span. There are standard measures and techniques available to evaluate children and adults for ADHD. Pharmacotherapy is highly effective in treating ADHD. Behavioral and psychosocial intervention can also address symptoms and comorbid disorders for individuals with ADHD./ 미리보기
Schweitzer, Julie B Saunders 2001
15 저널기사 Beyond Women's Health: The New Discipline of Gender-Specific Medicine/ 미리보기
Legato, M. J Saunders 2003
16 저널기사 Cardiac Pacing: A Review - Cardiac pacing is an ever-growing field in which cutting-edge technology combines with clinical judgment in the care of the patient. This review discusses clinical aspects, such as changes in pacing guidelines and new indications and uses for cardiac pacemakers. Technologic advances are reviewed, including sensor technology, new diagnostic tools, and automatic algorithms that contribute to patient safety and pacemaker longevity./ 미리보기
Glikson, Michael Saunders 2001
17 저널기사 Cardiovascular Risk in Women with Type 2 Diabetes/ 미리보기
Brandenburg, S. L Saunders 2003
18 저널기사 Catheter Ablation for Cardiac Arrhythmias - The safety and efficacy of catheter ablation for treatment of most types of cardiac arrhythmias are well established. These arrhythmias and arrhythmia substrates include AVNRT, accessory pathways, focal atrial tachycardia, atrial flutter, idiopathic ventricular tachycardia, and bundle-branch re-entry. Catheter ablation is considered as an alternative to pharmacologic therapy in the treatment of these cardiac arrhythmias./ 미리보기
Calkins, Hugh Saunders 2001
19 저널기사 Cerebrovascular Cases/ 미리보기
Fink, J. N Saunders 2003
20 저널기사 Clinical use of Fluoroquinolones - The quinolones have undergone a "structural evolution" since the inadvertent discovery of nalidixic acid in 1962. A better understanding of structure-activity and structure-toxicity relationships has allowed chemists to modify the adaptable quinolone structure to enhance or limit the extent of antimicrobial activity and to improve various other product attributes such as the pharmacokinetic profile, tolerability, drug interaction potential, and toxicity of each new agent. Ciprofloxacin and levofloxin/oflofloxin have demonstrated relatively clean safety profiles over several years of clinical use. Newer fluorquinolones should be fully evaluated by clinicians prior to their use so as to avoid potentially life-threatening adverse events. Several newer quinolones are available or are being investigated for clinical use, including gatifloxacin, moxifloxican, clinafloxacin, and gemifloxacin. Rare but life-threatening toxicities (e.g., cardiotoxicity, hepato 미리보기
Owens Jr, Robert C Saunders 2000
1 2 3 4 5 6 
임시보관함보기

하단메뉴